Circulating tumor cells (CTC) and prostate specific antigen (PSA) as response indicator biomarkers in chemotherapy-naive patients with progressive castration-resistant prostate cancer (CRPC) treated with MDV3100 Meeting Abstract

  

Authors:	Anand, A.; Scher, H. I.; Beer, T. M.; Higano, C. E.; Danila, D. C.; Taplin, M.; Efstathiou, E.; Hirmand, M.; Sawyers, C. L.; Heller, G.; for the Prostrate Cancer Clinical Trials Consortium
Abstract Title:	Circulating tumor cells (CTC) and prostate specific antigen (PSA) as response indicator biomarkers in chemotherapy-naive patients with progressive castration-resistant prostate cancer (CRPC) treated with MDV3100
Meeting Title:	46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	28
Issue:	15 Suppl.
Meeting Dates:	2010 Jun 4-8
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2010-05-20
Start Page:	353s
Language:	English
ACCESSION:	WOS:000208852003669
DOI:	10.1200/jco.2010.28.15_suppl.4546
PROVIDER:	wos
Notes:	Meeting Abstract: 4546 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/129401